Clinical Guidelines
Clinical Guidelines
-
AHCDO; 2023
-
AHCDO; 2023
The Australian Haemophilia Centre Directors' Organisation (AHCDO), has developed the Gene Therapy Roadmap to provide a Clinical Implementation Plan that sets out AHCDO’s position on the preferred approach to implementation of gene therapy for haemophilia in Australia, with a focus on patient needs that is informed by clinical experience.
If you have any questions or feedback, please direct your comments to info@ahcdo.org.au
-
The Australian Haemophilia Centre Directors’ Organisation, in consultation with the National Blood Authority, adopts the World Federation of Haemophilia Guidelines for the Management of Hemophilia, 3rd edition in full with the amendments / additions for the Australian context.
Download Position Statement (October 2024)
The Position Statement above should be read in conjunction with The framework for the management of bleeding disorders in Australia (The Framework); National Blood Authority; 2025 - link to The Framework
Previous Guidelines
RESCINDED Guidelines AHCDO and National Blood Authority; Version 1; 2016
If you have any questions or feedback, please direct your comments to info@ahcdo.org.au
Fact Sheets for Health Professionals
-
AHCDO and Haemophilia Foundation Australia; 2017
Outlines key points and includes information on who should be considered for testing, accessibility, co-infection, clinical management and bleeding disorder-related complications.
This is a collaborative publication from Australian Haemophilia Centre Directors’ Organisation (AHCDO) and Haemophilia Foundation Australia.